Insider Transactions in Q2 2023 at Prelude Therapeutics Inc (PRLD)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 25
2023
|
Krishna Vaddi CEO |
BUY
Open market or private purchase
|
Direct |
900
+0.08%
|
$4,500
$5.31 P/Share
|
|
May 24
2023
|
Krishna Vaddi CEO |
BUY
Open market or private purchase
|
Direct |
1,000
+0.09%
|
$5,000
$5.01 P/Share
|
|
May 24
2023
|
Bryant David Lim CLO, Interim CFO, Corp Sec. |
BUY
Open market or private purchase
|
Direct |
2,400
+50.0%
|
$12,000
$5.39 P/Share
|
|
May 23
2023
|
Laurent Chardonnet Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+10.6%
|
$25,000
$5.5 P/Share
|
|
May 23
2023
|
Krishna Vaddi CEO |
BUY
Open market or private purchase
|
Direct |
11,856
+1.1%
|
$59,280
$5.63 P/Share
|
|
May 22
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
869,565
+7.91%
|
$4,347,825
$5.75 P/Share
|
|
May 22
2023
|
David P Bonita |
BUY
Open market or private purchase
|
Indirect |
869,565
+7.91%
|
$4,347,825
$5.75 P/Share
|
|
Apr 06
2023
|
Jane Huang President, CMO |
SELL
Open market or private sale
|
Direct |
13,280
-35.41%
|
$79,680
$6.12 P/Share
|
|
Apr 04
2023
|
Jane Huang President, CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
37,500
+50.0%
|
-
|